23 May 2013
Keywords: steifel, acquires, barrier, 145m, deal, usa-based, dermatology
Article | 30 June 2008
USA-based dermatology specialist Stiefel Laboratories has signed a definitive agreement to acquire Barrier Therapeutics for $148.0 million.
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
30 June 2008
22 May 2013
© 2013 thepharmaletter.com